BCAS2, a protein enriched in superior prostate most cancers, interacts with NBS1 to reinforce DNA double-strand break restore
Background: Breast most cancers amplified sequence 2 (BCAS2) performs essential roles in pre-mRNA splicing and androgen receptor transcription. Earlier research urged that BCAS2 is concerned in double-strand breaks (DSB); due to this fact, we aimed to characterise its mechanism and position in prostate most cancers (PCa).
Strategies: Western blotting and immunofluorescence microscopy have been used to assay the roles of BCAS2 within the DSBs of PCa cells and apoptosis in Drosophila, respectively. The impact of BCAS2 dosage on non-homologous finish becoming a member of (NHEJ) and homologous recombination (HR) have been assayed by exact end-joining assay and move cytometry, respectively. Glutathione-S-transferase pulldown and co-immunoprecipitation assays have been used to find out whether or not and the way BCAS2 interacts with NBS1. The expression of BCAS2 and different proteins in human PCa was decided by immunohistochemistry.
Outcomes: BCAS2 helped restore radiation-induced DSBs effectively in each human PCa cells and Drosophila. BCAS2 enhanced each NHEJ and HR, probably by interacting with NBS1, which concerned the BCAS2 N-terminus as effectively as each the NBS1 N- and C-termini. The overexpression of BCAS2 was considerably related to larger Gleason and pathology grades and shorter survival in sufferers with PCa.
Conclusion: BCAS2 promotes two DSB restore pathways by interacting with NBS1, and it could have an effect on PCa development.

CSP Antibody |
|||
C15493-50ul | Assay Biotech | 50μl | EUR 143.5 |
Description: CSP Rabbit Polyclonal Antibody |
CSP Antibody |
|||
E38PA2793 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CSP Antibody |
|||
MBS5315730-01mL | MyBiosource | 0.1mL | EUR 470 |
CSP Antibody |
|||
MBS5315730-5x01mL | MyBiosource | 5x0.1mL | EUR 1955 |
CSP Antibody |
|||
MBS8581566-01mL | MyBiosource | 0.1mL | EUR 305 |
CSP Antibody |
|||
MBS8581566-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
CSP Antibody |
|||
MBS8581566-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
CSP Antibody |
|||
MBS8581566-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
CSP Antibody |
|||
MBS8581566-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
csp-3 Antibody |
|||
CSB-PA276715XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
Description: Recombinant Caenorhabditis elegans csp-3 protein |
csp-3 Antibody |
|||
CSB-PA276715XA01CXY-10mg | Cusabio | 10mg | Ask for price |
Description: Recombinant Caenorhabditis elegans csp-3 protein |
csp-1 Antibody |
|||
CSB-PA136494XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
Description: Recombinant Caenorhabditis elegans csp-1 protein |
csp-1 Antibody |
|||
CSB-PA136494XA01CXY-10mg | Cusabio | 10mg | Ask for price |
Description: Recombinant Caenorhabditis elegans csp-1 protein |
csp-2 Antibody |
|||
CSB-PA443560XA01CXY-02mg | Cusabio | 0.2mg | Ask for price |
Description: Recombinant Caenorhabditis elegans csp-2 protein |
csp-2 Antibody |
|||
CSB-PA443560XA01CXY-10mg | Cusabio | 10mg | Ask for price |
Description: Recombinant Caenorhabditis elegans csp-2 protein |
Polyclonal CSP Antibody |
|||
AMM05812G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CSP . This antibody is tested and proven to work in the following applications: |
CSP-beta Antibody |
|||
abx432070-100g | Abbexa | 100 µg | EUR 250 |
CSP-beta Antibody |
|||
abx432070-200ul | Abbexa | 200 ul | EUR 343.2 |
Anti-CSP Antibody |
|||
MBS820421-003mL | MyBiosource | 0.03mL | EUR 185 |
Anti-CSP Antibody |
|||
MBS820421-01mL | MyBiosource | 0.1mL | EUR 255 |
Anti-CSP Antibody |
|||
MBS820421-02mL | MyBiosource | 0.2mL | EUR 335 |
Anti-CSP Antibody |
|||
MBS820421-5x02mL | MyBiosource | 5x0.2mL | EUR 1420 |
Anti-CSP Antibody |
|||
MBS9239448-01mL | MyBiosource | 0.1mL | EUR 415 |
Anti-CSP Antibody |
|||
MBS9239448-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
Anti-CSP antibody |
|||
STJ92500 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to CSP. |
CSP Polyclonal Antibody |
|||
40789 | SAB | 100ul | EUR 319 |
CSP Polyclonal Antibody |
|||
40789-100ul | SAB | 100ul | EUR 302.4 |
CSP Polyclonal Antibody |
|||
40789-50ul | SAB | 50ul | EUR 224.4 |
CSP Polyclonal Antibody |
|||
ABP51061-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of CSP from Human, Mouse, Rat. This CSP antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human CSP at AA range: 100-180 |
CSP Polyclonal Antibody |
|||
ABP51061-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of CSP from Human, Mouse, Rat. This CSP antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human CSP at AA range: 100-180 |
CSP Polyclonal Antibody |
|||
ABP51061-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of CSP from Human, Mouse, Rat. This CSP antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human CSP at AA range: 100-180 |
CSP polyclonal antibody |
|||
BS62356 | Bioworld Biotech | 50ul | EUR 275 |
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
CSP Polyclonal Antibody |
|||
BT-AP02274-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
Description: DNAJC5 is a member of the J protein family. J proteins function in many cellular processes by regulating the ATPase activity of 70 kDa heat shock proteins. The encoded protein (DnaJ heat shock protein family (Hsp40) member C5) plays a role in membrane trafficking and protein folding, and has been shown to have anti-neurodegenerative properties. The encoded protein is known to play a role in cystic fibrosis and Huntington's disease. A pseudogene of DNAJC5 is located on the short arm of chromosome 8. |
CSP Polyclonal Antibody |
|||
BT-AP02274-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
Description: DNAJC5 is a member of the J protein family. J proteins function in many cellular processes by regulating the ATPase activity of 70 kDa heat shock proteins. The encoded protein (DnaJ heat shock protein family (Hsp40) member C5) plays a role in membrane trafficking and protein folding, and has been shown to have anti-neurodegenerative properties. The encoded protein is known to play a role in cystic fibrosis and Huntington's disease. A pseudogene of DNAJC5 is located on the short arm of chromosome 8. |
CSP Polyclonal Antibody |
|||
BT-AP02274-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
Description: DNAJC5 is a member of the J protein family. J proteins function in many cellular processes by regulating the ATPase activity of 70 kDa heat shock proteins. The encoded protein (DnaJ heat shock protein family (Hsp40) member C5) plays a role in membrane trafficking and protein folding, and has been shown to have anti-neurodegenerative properties. The encoded protein is known to play a role in cystic fibrosis and Huntington's disease. A pseudogene of DNAJC5 is located on the short arm of chromosome 8. |
CSP Polyclonal Antibody |
|||
JOT-AP02274-100ul | Jotbody | 100ul | EUR 220 |
Description: Human;Mouse;Rat |
CSP Polyclonal Antibody |
|||
JOT-AP02274-50ul | Jotbody | 50ul | EUR 144 |
Description: Human;Mouse;Rat |
CSP Polyclonal Antibody |
|||
E040789 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
CSP Polyclonal Antibody |
|||
E44H04427 | EnoGene | 100ul | EUR 255 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
CSP Polyclonal Antibody |
|||
E20-71135 | EnoGene | 100ug | EUR 225 |
Description: Available in various conjugation types. |
CSP polyclonal antibody |
|||
MBS565353-01mg | MyBiosource | 0.1mg | EUR 495 |
CSP polyclonal antibody |
|||
MBS565353-5x01mg | MyBiosource | 5x0.1mg | EUR 2075 |
CSP Polyclonal Antibody |
|||
MBS2535113-002mL | MyBiosource | 0.02mL | EUR 140 |
CSP Polyclonal Antibody |
|||
MBS2535113-006mL | MyBiosource | 0.06mL | EUR 180 |
CSP Polyclonal Antibody |
|||
MBS2535113-012mL | MyBiosource | 0.12mL | EUR 260 |
CSP Polyclonal Antibody |
|||
MBS2535113-02mL | MyBiosource | 0.2mL | EUR 405 |
CSP Polyclonal Antibody |
|||
MBS8522116-01mg | MyBiosource | 0.1mg | EUR 305 |
CSP Polyclonal Antibody |
|||
MBS8522116-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
CSP Polyclonal Antibody |
|||
MBS8522116-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
CSP Polyclonal Antibody |
|||
MBS8522116-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
CSP Polyclonal Antibody |
|||
MBS8522116-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
CSP Polyclonal Antibody |
|||
MBS9243248-01mL | MyBiosource | 0.1mL | EUR 415 |
CSP Polyclonal Antibody |
|||
MBS9243248-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
CSP Polyclonal Antibody |
|||
MBS9233786-01mL | MyBiosource | 0.1mL | EUR 415 |
CSP Polyclonal Antibody |
|||
MBS9233786-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
CSP Polyclonal Antibody |
|||
MBS9407290-005mL | MyBiosource | 0.05mL | EUR 245 |
CSP Polyclonal Antibody |
|||
MBS9407290-01mL | MyBiosource | 0.1mL | EUR 305 |
CSP Polyclonal Antibody |
|||
MBS9407290-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
CSP Polyclonal Antibody |
|||
UB-GEN-12518 | UpingBio | 100 ul | EUR 200 |
Plasmodium vivax CSP Antibody |
|||
abx022151-1mg | Abbexa | 1 mg | EUR 944.4 |
Plasmodium Vivax CSP Antibody |
|||
GWB-92F840 | GenWay Biotech | 0.2 mg | Ask for price |
Plasmodium vivax CSP Antibody |
|||
GWB-7738B9 | GenWay Biotech | 1 mg | Ask for price |
Plasmodium vivax CSP Antibody |
|||
GWB-418779 | GenWay Biotech | 1 mg | Ask for price |
Mouse Anti-P.falciparum CSP Recombinant Antibody |
|||
TRI-AB-012 | TRI Biotech | 0.1mg | EUR 1620 |
Mouse Anti Plasmodium Vivax Csp Monoclonal Antibody |
|||
DMABT-51495MP | Creative Diagnostics | 0.2 mg | EUR 567 |
Description: Mouse |
Mouse Anti-Plasmodium vivax CSP Monoclonal Antibody |
|||
DMAB4108 | Creative Diagnostics | 1 mg | EUR 719.04 |
Rabbit anti-CSP Antibody |
|||
DL91793A-100ul | DL Develop | 100 ul | EUR 325 |
Description: CSP; DnaJ homolog subfamily C member 5; Cysteine string protein; CSP |
Rabbit anti-CSP Antibody |
|||
DL91793A-50ul | DL Develop | 50 ul | EUR 227.5 |
Description: CSP; DnaJ homolog subfamily C member 5; Cysteine string protein; CSP |
Rabbit anti-CSP Antibody |
|||
YLD2210-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
Description: Rabbit polyclonal antibody to CSP |
Rabbit anti-CSP Antibody |
|||
YLD2210-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
Description: Rabbit polyclonal antibody to CSP |
CSP Rabbit Polyclonal Antibody |
|||
ES2060-100ul | ELK Biotech | 100ul | EUR 124 |
Description: WB, ELISA |
CSP Rabbit Polyclonal Antibody |
|||
ES2060-50ul | ELK Biotech | 50ul | EUR 74 |
Description: WB, ELISA |
Rabbit anti-Caenorhabditis elegans csp-3 Polyclonal Antibody |
|||
MBS7147487-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Caenorhabditis elegans csp-2 Polyclonal Antibody |
|||
MBS7170311-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Rabbit anti-Caenorhabditis elegans csp-1 Polyclonal Antibody |
|||
MBS7143908-INQUIRE | MyBiosource | INQUIRE | Ask for price |
CSP Polyclonal Conjugated Antibody |
|||
C40789 | SAB | 100ul | EUR 476.4 |
CSP Polyclonal Conjugated Antibody |
|||
MBS9449718-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
CSP Polyclonal Conjugated Antibody |
|||
MBS9449718-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
CSP Polyclonal Conjugated Antibody |
|||
MBS9449718-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
CSP Polyclonal Conjugated Antibody |
|||
MBS9449718-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
CSP Polyclonal Conjugated Antibody |
|||
MBS9449718-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
Polyclonal DNAJC5 / CSP Antibody (aa177-191) |
|||
APR11768G | Leading Biology | 0.05mg | EUR 580.8 |
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human DNAJC5 / CSP (aa177-191). This antibody is tested and proven to work in the following applications: |
Rabbit anti-Drosophila melanogaster (Fruit fly) Csp Polyclonal Antibody |
|||
MBS7150313-INQUIRE | MyBiosource | INQUIRE | Ask for price |
anti-CSP |
|||
YF-PA21083 | Abfrontier | 50 ug | EUR 435.6 |
Description: Mouse polyclonal to CSP |
Plasmodium vivax Circumsporozoite Protein (P. vivax CSP) Antibody |
|||
abx414618-02mg | Abbexa | 0.2 mg | EUR 678 |
Anti-CSP-beta (mouse aa177-190) antibody |
|||
STJ73524 | St John's Laboratory | 100 µg | EUR 312 |
CSP |
|||
5-01011 | CHI Scientific | 4 x 1mg | EUR 128.31 |
Description: Glu-Met-Arg-Leu-Ser-Lys-Phe-Phe-Arg-Asp-Phe-Ile-Leu-Gln-Arg-Lys-Lys |
CSP |
|||
MBS8246387-10mg | MyBiosource | 10mg | EUR 755 |
CSP |
|||
MBS8246387-1mg | MyBiosource | 1mg | EUR 270 |
CSP |
|||
MBS8246387-5mg | MyBiosource | 5mg | EUR 530 |
CSP |
|||
MBS8246387-5x10mg | MyBiosource | 5x10mg | EUR 3315 |
Goat anti-CSP-beta (mouse aa177-190) Antibody |
|||
dAP-3149 | Angio Proteomie | 50ug | EUR 264.6 |
Goat anti-CSP-beta (mouse aa177-190) Antibody |
|||
MBS423397-01mg | MyBiosource | 0.1mg | EUR 275 |
Goat anti-CSP-beta (mouse aa177-190) Antibody |
|||
MBS423397-5x01mg | MyBiosource | 5x0.1mg | EUR 1095 |
CSP Peptide |
|||
abx266729-1ml | Abbexa | 1 ml | EUR 412.5 |
CSP Peptide |
|||
abx266729-200l | Abbexa | 200 µl | EUR 212.5 |
Plasmodium vivax (circumsporozoite (CSP) mouse monoclonal antibody, clone PVC-2 |
|||
3PLV2-PVC-2 | Origene Technologies GmbH | 1 mg | Ask for price |
Plasmodium vivax CSP recombinant antigen |
|||
8968 | Virostat | 100 ug | EUR 529.8 |
Description: This is Plasmodium vivax CSP recombinant antigen for ELISA,WB. |
CSP-beta Peptide |
|||
43-589P | ProSci | 0.1 mg | EUR 405.6 |
CSP Blocking Peptide |
|||
20-abx063987 | Abbexa |
|
|
CSP Blocking Peptide |
|||
MBS824034-1mg | MyBiosource | 1mg | EUR 190 |
CSP Blocking Peptide |
|||
MBS824034-5mg | MyBiosource | 5mg | EUR 345 |
CSP Blocking Peptide |
|||
MBS824034-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
Plasmodium vivax CSP protein, Recombinant (malaria CSP pv) Protein |
|||
GWB-T00016 | GenWay Biotech | 1mg | Ask for price |
Mouse Monoclonal Anti-Circumsporozoite (CSP) (P. vivax) IgG, aff pure #1 |
|||
CSPV11-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Mouse Monoclonal Anti-Circumsporozoite (CSP) (P. vivax) IgG, aff pure #2 |
|||
CSPV12-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Cysteine String Protein (CSP) |
|||
MBS614840-01mg | MyBiosource | 0.1mg | EUR 685 |
Cysteine String Protein (CSP) |
|||
MBS614840-5x01mg | MyBiosource | 5x0.1mg | EUR 2935 |
Plasmodium vivax CSP Protein |
|||
abx060642-1mg | Abbexa | 1 mg | EUR 3567.6 |
PLASMODIUM VIVAX CSP PROTEIN |
|||
GWB-D19F34 | GenWay Biotech | 0.1 mg | Ask for price |
CSP-beta Immunizing Peptide |
|||
MBS428525-01mg | MyBiosource | 0.1mg | EUR 225 |
MAb to P. vivax CSP |
|||
MBS310454-INQUIRE | MyBiosource | INQUIRE | Ask for price |
anti- CSPP1 antibody |
|||
FNab02026 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against CSPP1 |
Competence-Stimulating Peptide-2 (CSP-2) |
|||
MBS5799190-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Competence-Stimulating Peptide-2 (CSP-2) |
|||
T38559-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Competence-Stimulating Peptide-2 (CSP-2) |
Competence-Stimulating Peptide-2 (CSP-2) |
|||
T38559-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Competence-Stimulating Peptide-2 (CSP-2) |
Competence-Stimulating Peptide-2 (CSP-2) |
|||
T38559-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Competence-Stimulating Peptide-2 (CSP-2) |
Competence-Stimulating Peptide-2 (CSP-2) |
|||
T38559-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Competence-Stimulating Peptide-2 (CSP-2) |
Competence-Stimulating Peptide-2 (CSP-2) |
|||
T38559-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Competence-Stimulating Peptide-2 (CSP-2) |
anti- CSPG4,NG2 antibody |
|||
FNab02025 | FN Test | 100µg | EUR 606.3 |
Description: Antibody raised against CSPG4,NG2 |
Plasmodium vivax CSP Recombinant Protein |
|||
53-353 | ProSci | 0.01 mg | EUR 714.3 |
Description: Plasmodium vivax CSP Recombinant Protein |
RECOMBINANT PLASMODIUM VIVAX CSP PROTEIN |
|||
MBS232087-01mg | MyBiosource | 0.1mg | EUR 1145 |
RECOMBINANT PLASMODIUM VIVAX CSP PROTEIN |
|||
MBS232087-5x01mg | MyBiosource | 5x0.1mg | EUR 4980 |
Anti-NG2/CSPG4 Antibody |
|||
MBS1753590-01mg | MyBiosource | 0.1mg | EUR 450 |
Anti-NG2/CSPG4 Antibody |
|||
MBS1753590-5x01mg | MyBiosource | 5x0.1mg | EUR 1870 |
Rabbit Anti-Circumsporozoite (CSP, P.falciparum) C-terminal (207-397 aa) His-tag protein antiserum |
|||
CSPF11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Anti-Human CSPG5 Antibody |
|||
MBS1569935-01mg | MyBiosource | 0.1mg | EUR 405 |
Anti-Human CSPG5 Antibody |
|||
MBS1569935-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Bolle Cobra COBCSP CSP Lens - EACH |
|||
SAF1902 | Scientific Laboratory Supplies | EACH | EUR 21.33 |
CSP (DNAJC5) (NM_025219) Human Recombinant Protein |
|||
E45H37917M5 | EnoGene | 20 ug | EUR 785.42 |
CSP (DNAJC5) (NM_025219) Human Recombinant Protein |
|||
PROTQ9H3Z4 | BosterBio | 20ug | EUR 1249 |
Description: Recombinant protein of human DnaJ (Hsp40) homolog, subfamily C, member 5 (DNAJC5) |
Recombinant (E. coli) Circumsporozoite (CSP; 353-aa and GST) antigen (P. vivax) |
|||
CSPV16-R | Alpha Diagnostics | 100 ug | EUR 634.8 |
OPMA04825-1MG - Plasmodium vivax CSP Protein |
|||
OPMA04825-1MG | Aviva Systems Biology | 1mg | EUR 2499 |
Recombinant Plasmodium Vivax CSP Protein [GST] |
|||
VAng-Wyb7856-100g | Creative Biolabs | 100 µg | EUR 1380 |
Description: Plasmodium Vivax CSP protein, recombinant protein. |
OPSA10797-100UG - PLASMODIUM VIVAX CSP Protein |
|||
OPSA10797-100UG | Aviva Systems Biology | 0.1mg | EUR 1139 |
YLKKIKNSL, P. falciparum circumsporozoite (CSP 334-342) polypeptide |
|||
CSPF15-P | Alpha Diagnostics | 1 mg | EUR 343.2 |
Anti-NG2/CSPG4 Antibody Picoband™ |
|||
A03394-3 | BosterBio | 10ug | EUR 154 |
Description: Western blot, 0.25-0.5μg/ml, Human;_x000D_Direct ELISA, 0.1-0.5μg/ml, Human |
Recombinant Plasmodium Vivax CSP (a.a. 353), GST-tagged |
|||
DAG448 | Creative Diagnostics | 1mg | EUR 1546.81 |
Description: Recombinant |
Anti-NG2 CSPG4 Rabbit Monoclonal Antibody |
|||
M03394 | BosterBio | 100ug/vial | EUR 154 |
Description: WB 1:500-1:2000 ;IHC 1:50-1:200 ;Flow Cytometry 1:50 |
Anti-NG2/Cspg4 Antibody, Rabbit Polyclonal |
|||
MBS8100816-01mL | MyBiosource | 0.1mL | EUR 300 |
Anti-NG2/Cspg4 Antibody, Rabbit Polyclonal |
|||
MBS8100816-5x01mL | MyBiosource | 5x0.1mL | EUR 1200 |
CSP (DNAJC5) (NM_025219) Human Over-expression Lysate |
|||
E45H12300-2 | EnoGene | each | EUR 395 |
CSP (DNAJC5) (NM_025219) Human Over-expression Lysate |
|||
LS080331 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of DnaJ (Hsp40) homolog, subfamily C, member 5 (DNAJC5) |
Cysteine string protein (CSP) Alpha, DNAJC5 alpha |
|||
MBS395741-01mg | MyBiosource | 0.1mg | EUR 440 |
Cysteine string protein (CSP) Alpha, DNAJC5 alpha |
|||
MBS395741-5x01mg | MyBiosource | 5x0.1mg | EUR 1820 |
Cysteine string protein (CSP) Alpha, DNAJC5 alpha |
|||
MBS395909-01mg | MyBiosource | 0.1mg | EUR 425 |
Cysteine string protein (CSP) Alpha, DNAJC5 alpha |
|||
MBS395909-5x01mg | MyBiosource | 5x0.1mg | EUR 1760 |
Anti-NG2 Purified CSPG4 Monoclonal Antibody |
|||
M03394-1 | BosterBio | 0.1mg | EUR 291 |
Description: Boster Bio Anti-NG2 Purified CSPG4 Monoclonal Antibody (Catalog# M03394-1). Tested in Flow Cytometry, IP, WB, ICC application(s). This antibody reacts with Human. |
Human Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgG ELISA kit, 96 tests, Quantitative |
|||
970-400-CHG | Alpha Diagnostics | 1 Kit | EUR 1000.8 |
Human Anti-Circumsporozoite protein (CSP, P falciparum/RTS,S vaccine) IgM ELISA kit, 96 tests, Quantitative |
|||
970-410-CHM | Alpha Diagnostics | 1 Kit | EUR 1000.8 |
Sequencing and Characterisation of Complete Mitochondrial DNA Genome for Trigonopoma pauciperforatum (Cypriniformes: Cyprinidae: Danioninae) with Phylogenetic Consideration
- The Trigonopoma pauciperforatum or the redstripe rasbora is a cyprinid generally present in marshes and swampy areas with slight acidic tannin-stained water within the tropics. On this research, the whole mitogenome sequence of pauciperforatum was first amplified in two components utilizing two pairs of overlapping primers after which sequenced.
- The dimensions of the mitogenome is 16,707 bp, encompassing 22 switch RNA genes, 13 protein-coding genes, two ribosomal RNA genes and a putative management area. An identical gene organisation was detected between this species and different members of the family.
- The heavy strand accommodates 28 genes whereas the sunshine strand homes the remaining 9 genes. Most protein-coding genes utilise ATG as begin codon aside from COI gene which makes use of GTG as an alternative. The terminal related sequence (TAS), central conserved sequence block (CSB-F, CSB-D and CSB-E) in addition to variable sequence block (CSB-1, CSB-2 and CSB-3) are conserved within the management area.
- The utmost probability phylogenetic tree revealed the divergence of pauciperforatum from the basal area of the foremost clade, the place its evolutionary relationships with Boraras maculatus, Rasbora cephalotaenia and R. daniconius are poorly resolved as urged by the low bootstrap values.
- This work contributes in the direction of the genetic useful resource enrichment for peat swamp conservation and complete in-depth comparisons throughout different phylogenetic researches completed on the Rasbora-related genus.
Reconstructing double-stranded DNA fragments on a single-molecule degree reveals patterns of degradation in historic samples
Intensive manipulations concerned within the preparation of DNA samples for sequencing have hitherto made it unimaginable to find out the exact construction of double-stranded DNA fragments being sequenced, such because the presence of blunt ends, single-stranded overhangs, or single-strand breaks.
We right here describe MatchSeq, a technique that mixes single-stranded DNA library preparation from diluted DNA samples with computational sequence matching, permitting the reconstruction of double-stranded DNA fragments on a single-molecule degree.
The appliance of MatchSeq to Neanderthal DNA, a very advanced supply of degraded DNA, reveals that 1- or 2-nt overhangs and blunt ends dominate the ends of historic DNA molecules and that brief gaps exist, that are predominantly brought on by the lack of particular person purines.
We additional present that deamination of cytosine to uracil happens in each single- and double-stranded contexts near the ends of molecules, and that single-stranded components of DNA fragments are enriched in pyrimidines. MatchSeq supplies unprecedented decision for interrogating the buildings of fragmented double-stranded DNA and could be utilized to fragmented double-stranded DNA remoted from any organic supply. The tactic depends on well-established laboratory methods and might simply be built-in into routine knowledge era.
This risk is proven by the profitable reconstruction of double-stranded DNA fragments from beforehand revealed single-stranded sequence knowledge, permitting a extra complete characterization of the biochemical properties not solely of historic DNA but in addition of cell-free DNA from human blood plasma, a clinically related marker for the analysis and monitoring of illness.
Orf Virus VEGF-E |
|||
MBS691947-0002mg | MyBiosource | 0.002mg | EUR 265 |
Orf Virus VEGF-E |
|||
MBS691947-5x0002mg | MyBiosource | 5x0.002mg | EUR 890 |
VEGF E (Orf Virus) |
|||
cyt-263 | ProSpec Tany | 2µg | EUR 60 |
Description: Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691480-002mg | MyBiosource | 0.02mg | EUR 440 |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691480-5x002mg | MyBiosource | 5x0.02mg | EUR 1685 |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691994-0005mg | MyBiosource | 0.005mg | EUR 300 |
Orf Virus VEGF-E, Heparin-binding |
|||
MBS691994-5x0005mg | MyBiosource | 5x0.005mg | EUR 1050 |
Orf virus VEGF-E Recombinant Protein |
|||
300-044 | ReliaTech | 5 µg | EUR 136.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|||
300-044S | ReliaTech | 2 µg | EUR 73.5 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Orf virus VEGF-E Recombinant Protein |
|||
300-045 | ReliaTech | 20 µg | EUR 357 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999; Wise et al., 1999). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E can not bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Anti-Orf Virus VEGF-E Antibody |
|||
102-PA70 | ReliaTech | 50 µg | EUR 115.5 |
Description: A DNA sequence encoding the mature variant of ov-VEGF-E isolate D1701 was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV). Different isolates of Orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appears to be derived from captured host genes. All eight Cysteine residues of the central Cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins. Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E cannot bind to VEGF receptor-1 (Flt-1). Furthermore VEGF-E can also not bind to VEGF receptor-3 (FLT-4). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor –2/KDR. |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-1mg |
|||
QP10912-1mg | EnQuireBio | 1mg | EUR 6181.2 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug |
|||
QP10912-2ug | EnQuireBio | 2ug | EUR 186 |
Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-10ug |
|||
QP10912-10ug | EnQuireBio | 10ug | EUR 241.2 |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|||
300-046 | ReliaTech | 20 µg | EUR 194.25 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
Orf virus VEGF-E, Heparin-binding Recombinant Protein |
|||
300-046S | ReliaTech | 5 µg | EUR 94.5 |
Description: A DNA sequence encoding the first 116 amino acid residue of Orf virus VEGF-E isolate D1701 (Dehio et al., 1999 EMBO J. 18:363-374; GenBank accession No. AF106020) was fused with a DNA sequence encoding to the C-terminal heparin binding domain of human VEGF165. The chimeric protein was expressed in insect cells using a baculovirus expression system. Based on sequence similarity to VEGF-A, a gene encoding a VEGF homologue has recently been discovered in the genome of Orf virus (OV) (Lyttle et al., 1994 J. Virol 68:84-92). Different isolates of orf virus show significant amino acid sequence similarity to VEGF-A and described as a viral virulence factor that appear to be derived from captured host genes. All eight cysteine residues of the central cysteine knot motif characteristic of members of the VEGF family are conserved among other residues in the VEGF-E proteins (Dehio et al., 1999 EMBO J. 18:363-374; Wise et al., 1999 Proc. Natl. Acad. Sci USA 96:3071-3076). Alignment of all mammalian VEGF sequences indicated that VEGF-E is distinct from the previously described VEGFs but most closely related to VEGF-A. Like VEGF-A, VEGF-E was found to bind with high affinity to VEGF receptor-2 (KDR) resulting in receptor autophosphorylation, whilst in contrast to VEGF-A, VEGF-E and hb-VEGF-E can not bind to VEGF receptor-1 (Flt-1). Therefore VEGF-E is a potent angiogenic factor selectively binding to VEGF receptor–2/ KDR. Compared to human VEGF165 this virus form has no heparin-binding domain and seems to be a freely secreted protein comparable to VEGF121. In order to compare this form with human VEGF165, an additional heparin-binding domain was engineered at the C-terminus to allow interaction with proteo-aminoglycans and heparan sulfate. These form is also able to interact with neuropillin–1. |
VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus) |
|||
PROTQ2F842 | BosterBio | Regular: 10ug | EUR 250 |
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa. |
ov-VEGF-E (Orf virus) (Recombinant) Human |
|||
GWB-C8AD60 | GenWay Biotech | 0.005 mg | Ask for price |
VEGFE protein (Orf virus) |
|||
30R-AV011 | Fitzgerald | 5 ug | EUR 381 |
Description: Purified recombinant VEGFE protein (Orf virus) |
VEGFE protein (Orf virus) |
|||
MBS538323-0005mg | MyBiosource | 0.005mg | EUR 505 |
VEGFE protein (Orf virus) |
|||
MBS538323-5x0005mg | MyBiosource | 5x0.005mg | EUR 2125 |
Recombinant Orf Virus VEGFE Protein |
|||
VAng-Lsx0417-inquire | Creative Biolabs | inquire | Ask for price |
Description: Orf Virus VEGFE, recombinant protein from Baculovirus. |
Recombinant Orf Virus VEGFE Protein [His] |
|||
VAng-Lsx0418-inquire | Creative Biolabs | inquire | Ask for price |
Description: Orf Virus VEGFE [His], recombinant protein from E. coli. |
Cytochalasin E |
|||
C197-1MG | TOKU-E | 1 mg | EUR 79.77 |
Description: 36011-19-5 |
Cytochalasin E |
|||
C197-5MG | TOKU-E | 5 mg | EUR 276.58 |
Description: 36011-19-5 |
Chevalone E |
|||
C257-0.5MG | TOKU-E | 0.5 mg | EUR 153.46 |
Description: 1315451-94-5 |
Chevalone E |
|||
C257-2.5MG | TOKU-E | 2.5 mg | EUR 536.69 |
Description: 1315451-94-5 |
Berkeleylactone E |
|||
B087-1MG | TOKU-E | 1 mg | EUR 145.66 |
Description: 122211-62-5 |
Berkeleylactone E |
|||
B087-5MG | TOKU-E | 5 mg | EUR 509.81 |
Description: 122211-62-5 |
Deoxybrevianamide E |
|||
D083-1MG | TOKU-E | 1 mg | EUR 191.61 |
Description: 34610-68-9 |
Deoxybrevianamide E |
|||
D083-5MG | TOKU-E | 5 mg | EUR 670.21 |
Description: 34610-68-9 |
Oligomycin E |
|||
O021-1MG | TOKU-E | 1 mg | EUR 212.42 |
Description: 110231-34-0 |
Oligomycin E |
|||
O021-5MG | TOKU-E | 5 mg | EUR 741.31 |
Description: 110231-34-0 |
Paraherquamide E |
|||
P070-0.5MG | TOKU-E | 0.5 mg | EUR 271.38 |
Description: 125600-53-5 |
Paraherquamide E |
|||
P070-2.5MG | TOKU-E | 2.5 mg | EUR 947.66 |
Description: 125600-53-5 |
Phenelfamycin E |
|||
P078-1MG | TOKU-E | 1 mg | EUR 212.42 |
Description: 114451-31-9 |
Phenelfamycin E |
|||
P078-5MG | TOKU-E | 5 mg | EUR 741.31 |
Description: 114451-31-9 |
Roquefortine E |
|||
R035-1MG | TOKU-E | 1 mg | EUR 150 |
Description: 871982-52-4 |
Roquefortine E |
|||
R035-5MG | TOKU-E | 5 mg | EUR 524.55 |
Description: 871982-52-4 |
Azithromycin impurity E EvoPure® |
|||
A074-5MG | TOKU-E | 5 mg | EUR 605.18 |
Description: 612069-27-9 |
Hepatitis E virus ORF 3 Recombinant Protein |
|||
53-335 | ProSci | 0.01 mg | EUR 651.3 |
Description: Hepatitis E virus ORF 3 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|||
53-336 | ProSci | 0.01 mg | EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Hepatitis E virus ORF 2 Recombinant Protein |
|||
53-337 | ProSci | 0.01 mg | EUR 651.3 |
Description: Hepatitis E virus ORF 2 Recombinant Protein |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
abx263083-10mg | Abbexa | 10 mg | EUR 325 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
20-abx263083 | Abbexa |
|
|
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
abx263083-25mg | Abbexa | 25 mg | EUR 6500 |
Vascular Endothelial Growth Factor-E (Orf Virus) Protein |
|||
abx263083-5mg | Abbexa | 5 mg | EUR 225 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 990 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 555 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 745 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 660 |
Recombinant Vaccinia virus Uncharacterized 7.6 kDa protein (E ORF E) |
|||
MBS1007472-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 870 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
7-01759 | CHI Scientific | 2µg | Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
7-01760 | CHI Scientific | 10µg | Ask for price |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
7-01761 | CHI Scientific | 1mg | Ask for price |
Vascular Endothelial Growth Factor-E (Orf Virus), (Recombinant) |
|||
22060748-1 | Bio-WORLD | 2 µg | EUR 190.94 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
cyt-263-10g | ProSpec Tany | 10µg | EUR 145 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
cyt-263-1mg | ProSpec Tany | 1mg | EUR 5100 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
cyt-263-2g | ProSpec Tany | 2µg | EUR 60 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-1mg | MyBiosource | 1mg | EUR 5325 |
Recombinant Vascular Endothelial Growth Factor-E (Orf Virus) |
|||
MBS142140-5x1mg | MyBiosource | 5x1mg | EUR 23640 |
Vascular Endothelial Growth Factor-E Recombinant (Orf Virus) |
|||
rAP-2496 | Angio Proteomie | Inquiry | Ask for price |
Hepatitis E Virus ORF3 Protein |
|||
20-abx260138 | Abbexa |
|
|
Hepatitis E Virus ORF3 Protein |
|||
abx260138-20g | Abbexa | 20 µg | EUR 950 |
Hepatitis E Virus ORF3 Protein |
|||
abx260138-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E virus |
|||
8942 | Virostat | 100 ug | EUR 340 |
Description: ORF 2 |
Hepatitis E virus |
|||
8943 | Virostat | 100 ug | EUR 340 |
Description: ORF 2 |
Hepatitis E virus |
|||
8944 | Virostat | 100 ug | EUR 340 |
Description: ORF 3 |
Hepatitis E virus |
|||
MBS328020-01mg | MyBiosource | 0.1mg | EUR 435 |
Hepatitis E virus |
|||
MBS328020-5x01mg | MyBiosource | 5x0.1mg | EUR 1865 |
Hepatitis E virus |
|||
MBS328021-01mg | MyBiosource | 0.1mg | EUR 435 |
Hepatitis E virus |
|||
MBS328021-5x01mg | MyBiosource | 5x0.1mg | EUR 1865 |
Hepatitis E virus |
|||
MBS328022-01mg | MyBiosource | 0.1mg | EUR 435 |
Hepatitis E virus |
|||
MBS328022-5x01mg | MyBiosource | 5x0.1mg | EUR 1865 |
Hepatitis E virus |
|||
PCR-H498-PCRH49848R | Bioingentech | PCR-H498-48R | EUR 485 |
Hepatitis E virus |
|||
PCR-H498-PCRH49896R | Bioingentech | PCR-H498-96R | EUR 685 |
Hepatitis E virus |
|||
Oneq-H498-OneqH498100R | Bioingentech | Oneq-H498-100R | EUR 1028 |
Hepatitis E virus |
|||
Oneq-H498-OneqH498150R | Bioingentech | Oneq-H498-150R | EUR 1438 |
Hepatitis E virus |
|||
Oneq-H498-OneqH49850R | Bioingentech | Oneq-H498-50R | EUR 728 |
Recombinant Hepatitis E Virus ORF3 |
|||
7-07450 | CHI Scientific | 100µg | Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|||
7-07451 | CHI Scientific | 500µg | Ask for price |
Recombinant Hepatitis E Virus ORF3 |
|||
7-07452 | CHI Scientific | 1000µg | Ask for price |
Hepatitis E Virus ORF3 (Recombinant) |
|||
22060181-1 | Bio-WORLD | 100 µg | EUR 344.89 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-01mg | MyBiosource | 0.1mg | EUR 330 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-05mg | MyBiosource | 0.5mg | EUR 825 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-1mg | MyBiosource | 1mg | EUR 1515 |
Recombinant Hepatitis E Virus ORF3 |
|||
MBS142588-5x1mg | MyBiosource | 5x1mg | EUR 6485 |
Hepatitis E Virus ORF3 Recombinant |
|||
rAP-5321 | Angio Proteomie | Inquiry | Ask for price |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|||
MBS637880-01mg | MyBiosource | 0.1mg | EUR 455 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|||
MBS637880-05mg | MyBiosource | 0.5mg | EUR 1025 |
Hepatitis E Virus, ORF2, Recombinant (HEV) |
|||
MBS637880-5x05mg | MyBiosource | 5x0.5mg | EUR 4470 |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
|||
MBS636730-01mg | MyBiosource | 0.1mg | EUR 735 |
Hepatitis E Virus, ORF3, Recombinant (HEV) |
|||
MBS636730-5x01mg | MyBiosource | 5x0.1mg | EUR 3155 |
VEGF (165): Human Recombinant E Coli |
|||
GWB-BDEFEF | GenWay Biotech | 1 mg | Ask for price |
OPPA00528-2UG - VEGF E Protein |
|||
OPPA00528-2UG | Aviva Systems Biology | 2ug | EUR 70 |
Hepatitis E Virus ORF2 (452-617) Protein |
|||
20-abx260268 | Abbexa |
|
|
Hepatitis E Virus ORF2 (452-617) Protein |
|||
abx260268-20g | Abbexa | 20 µg | EUR 950 |
Hepatitis E Virus ORF2 (452-617) Protein |
|||
abx260268-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E Virus ORF2 (633-659) Protein |
|||
20-abx260269 | Abbexa |
|
|
Hepatitis E Virus ORF2 (633-659) Protein |
|||
abx260269-25g | Abbexa | 25 µg | EUR 950 |
Hepatitis E Virus ORF2 (633-659) Protein |
|||
abx260269-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E Virus ORF2 (403-461) Protein |
|||
20-abx260270 | Abbexa |
|
|
Hepatitis E Virus ORF2 (403-461) Protein |
|||
abx260270-25g | Abbexa | 25 µg | EUR 950 |
Hepatitis E Virus ORF2 (403-461) Protein |
|||
abx260270-5g | Abbexa | 5 µg | EUR 350 |
Hepatitis E virus (ratHEV) |
|||
PCR-V372-PCRV37248R | Bioingentech | PCR-V372-48R | EUR 485 |
Hepatitis E virus (ratHEV) |
|||
PCR-V372-PCRV37296R | Bioingentech | PCR-V372-96R | EUR 685 |
Hepatitis E virus (ratHEV) |
|||
Oneq-V372-OneqV372100R | Bioingentech | Oneq-V372-100R | EUR 1028 |
Hepatitis E virus (ratHEV) |
|||
Oneq-V372-OneqV372150R | Bioingentech | Oneq-V372-150R | EUR 1438 |
Hepatitis E virus (ratHEV) |
|||
Oneq-V372-OneqV37250R | Bioingentech | Oneq-V372-50R | EUR 728 |